WithdrawnPhase 4

Ceftaroline in the Treatment of Bone and Joint Infections

Stopped: Failed to enroll any patients despite study modifications

United States0Started 2013-04

Plain-language summary

This is a study to evaluate the efficacy of Ceftaroline in the treatment of bone and joint infections.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Infected prosthetic knee or hip (first or second episode) with 2 stage procedure planned.
. Sinus tract which communicates with the joint
. Preoperative diagnosis by diagnostic, culture positive arthrocentesis
. Intraoperative diagnosis-evidence of purulence/inflammation is seen by the surgeon and/or the pathologist, and at least 2 intraoperative samples grow the same organism (only 1 needed if S. aureus) OR
. Acute osteomyelitis of an extremity Criteria for acute osteomyelitis (all 4 needed)
. Onset less than 4 weeks prior to evaluation
. Radiographic (plain, MRI, TC) evidence of osteomyelitis
. Positive culture from bone or blood culture with organism known to cause osteomyelitis

Exclusion criteria

. Immunocompromised hosts:
. AIDS/HIV patients
. Cancer requiring ongoing chemotherapy or radiation therapy steroid on an ongoing basis.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Sustained clinical remission from the treated osteoarticular infection

Timeframe: 1 year after study drug completion

Trial details

NCT IDNCT02005068

SponsorOrlando Health, Inc.

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-07

View on ClinicalTrials.gov More Osteomyelitis trials